Varioliform gastritis and duodenitis associated with protein-losing gastroenteropathy, treated with omeprazole
Identifieur interne : 000009 ( Main/Exploration ); précédent : 000008; suivant : 000010Varioliform gastritis and duodenitis associated with protein-losing gastroenteropathy, treated with omeprazole
Auteurs : RBID : ISTEX:535_1996_Article_BF01211196.pdfEnglish descriptors
Abstract
A 44-year-old female with varioliform gastritis and duodenitis had gastrointestinal protein loss revealed by111indium chloride scintigraphy. Treatment with omeprazole, a proton pump inhibitor, for 2 months, followed by famotidine, resulted in clinical improvement with resolution of the gastroduodenal lesions and protein loss. Colonization of the stomach withHelicobacter pylori was found before and after the treatment. The results in this patient suggest that omeprazole can be of value for the treatment of varioliform gastritis associated with protein-losing gastroenteropathy. The role ofHelicobacter pylori in the pathogenesis of this disease is unclear.
DOI: 10.1007/BF01211196
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title>Varioliform gastritis and duodenitis associated with protein-losing gastroenteropathy, treated with omeprazole</title><author><name>Ikuo Murata</name><affiliation wicri:level="1"><mods:affiliation>The Third Department of Internal Medicine, University of Occupational and Environmental Health, Japan</mods:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>The Third Department of Internal Medicine, University of Occupational and Environmental Health</wicri:regionArea><wicri:noRegion>University of Occupational and Environmental Health</wicri:noRegion></affiliation><affiliation wicri:level="1"><mods:affiliation>School of Medicine, 1-1 Iseigaoka, Yahatanishi-ku, 807, Kitakyushu City, Japan</mods:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>School of Medicine, 1-1 Iseigaoka, Yahatanishi-ku, 807, Kitakyushu City</wicri:regionArea><wicri:noRegion>Kitakyushu City</wicri:noRegion></affiliation></author><author><name>Ichiro Yoshikawa</name><affiliation wicri:level="1"><mods:affiliation>The Third Department of Internal Medicine, University of Occupational and Environmental Health, Japan</mods:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>The Third Department of Internal Medicine, University of Occupational and Environmental Health</wicri:regionArea><wicri:noRegion>University of Occupational and Environmental Health</wicri:noRegion></affiliation><affiliation wicri:level="1"><mods:affiliation>School of Medicine, 1-1 Iseigaoka, Yahatanishi-ku, 807, Kitakyushu City, Japan</mods:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>School of Medicine, 1-1 Iseigaoka, Yahatanishi-ku, 807, Kitakyushu City</wicri:regionArea><wicri:noRegion>Kitakyushu City</wicri:noRegion></affiliation></author><author><name>Tomohiro Kuroda</name><affiliation wicri:level="1"><mods:affiliation>The Third Department of Internal Medicine, University of Occupational and Environmental Health, Japan</mods:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>The Third Department of Internal Medicine, University of Occupational and Environmental Health</wicri:regionArea><wicri:noRegion>University of Occupational and Environmental Health</wicri:noRegion></affiliation><affiliation wicri:level="1"><mods:affiliation>School of Medicine, 1-1 Iseigaoka, Yahatanishi-ku, 807, Kitakyushu City, Japan</mods:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>School of Medicine, 1-1 Iseigaoka, Yahatanishi-ku, 807, Kitakyushu City</wicri:regionArea><wicri:noRegion>Kitakyushu City</wicri:noRegion></affiliation></author><author><name>Akinari Tabaru</name><affiliation wicri:level="1"><mods:affiliation>The Third Department of Internal Medicine, University of Occupational and Environmental Health, Japan</mods:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>The Third Department of Internal Medicine, University of Occupational and Environmental Health</wicri:regionArea><wicri:noRegion>University of Occupational and Environmental Health</wicri:noRegion></affiliation><affiliation wicri:level="1"><mods:affiliation>School of Medicine, 1-1 Iseigaoka, Yahatanishi-ku, 807, Kitakyushu City, Japan</mods:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>School of Medicine, 1-1 Iseigaoka, Yahatanishi-ku, 807, Kitakyushu City</wicri:regionArea><wicri:noRegion>Kitakyushu City</wicri:noRegion></affiliation></author><author><name>Tsutomu Miura</name><affiliation wicri:level="1"><mods:affiliation>Miura Clinic, Kitakyushu City, Japan</mods:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Miura Clinic, Kitakyushu City</wicri:regionArea><wicri:noRegion>Kitakyushu City</wicri:noRegion></affiliation></author><author><name>Makoto Otsuki</name><affiliation wicri:level="1"><mods:affiliation>The Third Department of Internal Medicine, University of Occupational and Environmental Health, Japan</mods:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>The Third Department of Internal Medicine, University of Occupational and Environmental Health</wicri:regionArea><wicri:noRegion>University of Occupational and Environmental Health</wicri:noRegion></affiliation><affiliation wicri:level="1"><mods:affiliation>School of Medicine, 1-1 Iseigaoka, Yahatanishi-ku, 807, Kitakyushu City, Japan</mods:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>School of Medicine, 1-1 Iseigaoka, Yahatanishi-ku, 807, Kitakyushu City</wicri:regionArea><wicri:noRegion>Kitakyushu City</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="RBID">ISTEX:535_1996_Article_BF01211196.pdf</idno><date when="1996">1996</date><idno type="doi">10.1007/BF01211196</idno><idno type="wicri:Area/Main/Corpus">000518</idno><idno type="wicri:Area/Main/Curation">000518</idno><idno type="wicri:Area/Main/Exploration">000009</idno></publicationStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Helicobacter pylori</term><term>Omeprazole</term><term>Protein-losing gastroenteropathy</term><term>Varioliform gastritis</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="eng">A 44-year-old female with varioliform gastritis and duodenitis had gastrointestinal protein loss revealed by111indium chloride scintigraphy. Treatment with omeprazole, a proton pump inhibitor, for 2 months, followed by famotidine, resulted in clinical improvement with resolution of the gastroduodenal lesions and protein loss. Colonization of the stomach withHelicobacter pylori was found before and after the treatment. The results in this patient suggest that omeprazole can be of value for the treatment of varioliform gastritis associated with protein-losing gastroenteropathy. The role ofHelicobacter pylori in the pathogenesis of this disease is unclear.</div></front></TEI><mods xsi:schemaLocation="http://www.loc.gov/mods/v3 file:///applis/istex/home/loadistex/home/etc/xsd/mods.xsd" version="3.4" istexId="5ab05bbbab88a0f28e43940816301f8c0cf6e6e6"><titleInfo lang="eng"><title>Varioliform gastritis and duodenitis associated with protein-losing gastroenteropathy, treated with omeprazole</title></titleInfo><name type="personal"><namePart type="given">Ikuo</namePart><namePart type="family">Murata</namePart><role><roleTerm type="text">author</roleTerm></role><affiliation>The Third Department of Internal Medicine, University of Occupational and Environmental Health, Japan</affiliation><affiliation>School of Medicine, 1-1 Iseigaoka, Yahatanishi-ku, 807, Kitakyushu City, Japan</affiliation></name><name type="personal"><namePart type="given">Ichiro</namePart><namePart type="family">Yoshikawa</namePart><role><roleTerm type="text">author</roleTerm></role><affiliation>The Third Department of Internal Medicine, University of Occupational and Environmental Health, Japan</affiliation><affiliation>School of Medicine, 1-1 Iseigaoka, Yahatanishi-ku, 807, Kitakyushu City, Japan</affiliation></name><name type="personal"><namePart type="given">Tomohiro</namePart><namePart type="family">Kuroda</namePart><role><roleTerm type="text">author</roleTerm></role><affiliation>The Third Department of Internal Medicine, University of Occupational and Environmental Health, Japan</affiliation><affiliation>School of Medicine, 1-1 Iseigaoka, Yahatanishi-ku, 807, Kitakyushu City, Japan</affiliation></name><name type="personal"><namePart type="given">Akinari</namePart><namePart type="family">Tabaru</namePart><role><roleTerm type="text">author</roleTerm></role><affiliation>The Third Department of Internal Medicine, University of Occupational and Environmental Health, Japan</affiliation><affiliation>School of Medicine, 1-1 Iseigaoka, Yahatanishi-ku, 807, Kitakyushu City, Japan</affiliation></name><name type="personal"><namePart type="given">Tsutomu</namePart><namePart type="family">Miura</namePart><role><roleTerm type="text">author</roleTerm></role><affiliation>Miura Clinic, Kitakyushu City, Japan</affiliation></name><name type="personal"><namePart type="given">Makoto</namePart><namePart type="family">Otsuki</namePart><role><roleTerm type="text">author</roleTerm></role><affiliation>The Third Department of Internal Medicine, University of Occupational and Environmental Health, Japan</affiliation><affiliation>School of Medicine, 1-1 Iseigaoka, Yahatanishi-ku, 807, Kitakyushu City, Japan</affiliation></name><typeOfResource>text</typeOfResource><genre>Case Report</genre><genre>Original Paper</genre><originInfo><publisher>Springer-Verlag, Tokyo</publisher><dateCreated encoding="w3cdtf">1994-03-28</dateCreated><dateCaptured encoding="w3cdtf">1995-04-28</dateCaptured><dateValid encoding="w3cdtf">2005-02-07</dateValid><copyrightDate encoding="w3cdtf">1996</copyrightDate></originInfo><language><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType></physicalDescription><abstract lang="eng">A 44-year-old female with varioliform gastritis and duodenitis had gastrointestinal protein loss revealed by111indium chloride scintigraphy. Treatment with omeprazole, a proton pump inhibitor, for 2 months, followed by famotidine, resulted in clinical improvement with resolution of the gastroduodenal lesions and protein loss. Colonization of the stomach withHelicobacter pylori was found before and after the treatment. The results in this patient suggest that omeprazole can be of value for the treatment of varioliform gastritis associated with protein-losing gastroenteropathy. The role ofHelicobacter pylori in the pathogenesis of this disease is unclear.</abstract><subject lang="eng"><genre>Key words</genre><topic>varioliform gastritis</topic><topic>protein-losing gastroenteropathy</topic><topic>Helicobacter pylori</topic><topic>omeprazole</topic></subject><relatedItem type="series"><titleInfo type="abbreviated"><title>J Gastroenterol</title></titleInfo><titleInfo><title>Journal of Gastroenterology</title><partNumber>Year: 1996</partNumber><partNumber>Volume: 31</partNumber><partNumber>Number: 1</partNumber></titleInfo><genre>Archive Journal</genre><originInfo><dateIssued encoding="w3cdtf">1996-01-01</dateIssued><copyrightDate encoding="w3cdtf">1996</copyrightDate></originInfo><subject usage="primary"><topic>Medicine & Public Health</topic><topic>Internal Medicine</topic><topic>Gastroenterology</topic><topic>Hepatology</topic><topic>Oncology</topic><topic>Surgical Oncology</topic><topic>Colorectal Surgery</topic></subject><identifier type="issn">0944-1174</identifier><identifier type="issn">Electronic: 1435-5922</identifier><identifier type="matrixNumber">535</identifier><identifier type="local">IssueArticleCount: 27</identifier><recordInfo><recordOrigin>Springer-Verlag, 1996</recordOrigin></recordInfo></relatedItem><identifier type="doi">10.1007/BF01211196</identifier><identifier type="matrixNumber">Art18</identifier><identifier type="local">BF01211196</identifier><accessCondition type="use and reproduction">MetadataGrant: OpenAccess</accessCondition><accessCondition type="use and reproduction">AbstractGrant: OpenAccess</accessCondition><accessCondition type="restriction on access">BodyPDFGrant: Restricted</accessCondition><accessCondition type="restriction on access">BodyHTMLGrant: Restricted</accessCondition><accessCondition type="restriction on access">BibliographyGrant: Restricted</accessCondition><accessCondition type="restriction on access">ESMGrant: Restricted</accessCondition><part><extent unit="pages"><start>109</start><end>113</end></extent></part><recordInfo><recordOrigin>Springer-Verlag, 1996</recordOrigin><recordIdentifier>535_1996_Article_BF01211196.pdf</recordIdentifier></recordInfo></mods></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=IndiumV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000009 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000009 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= *** parameter Area/wikiCode missing ***
|area= IndiumV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:535_1996_Article_BF01211196.pdf
|texte= Varioliform gastritis and duodenitis associated with protein-losing gastroenteropathy, treated with omeprazole
}}
| This area was generated with Dilib version V0.5.81. |  |